Exane Derivatives’s iShares MSCI USA Value Factor ETF VLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1
Closed -$74 867
2020
Q3
$74 Hold
1
﹤0.01% 732
2020
Q2
$72 Sell
1
-24,940
-100% -$1.74M ﹤0.01% 670
2020
Q1
$1.57M Sell
24,941
-5,073
-17% -$410K 0.44% 57
2019
Q4
$2.69M Sell
30,014
-986
-3% -$84.6K 0.5% 65
2019
Q3
$2.54M Buy
+31,000
New +$2.51M 0.46% 60

Other funds holding VLUE

Exane Derivatives's VLUE Position: Q4 2020 in Review

Exane Derivatives sold out of iShares MSCI USA Value Factor ETF (VLUE) in Q4 2020, closing a stake of 1 share — an estimated $74 sold.

Exane Derivatives first reported a position in VLUE in Q3 2019 and held it in 5 quarters. The position peaked at $2.69M in Q4 2019. 389 funds tracked by Wall St. Rank hold VLUE as of Q4 2020.

  • Exane Derivatives reported no remaining iShares MSCI USA Value Factor ETF position as of Q4 2020 after selling out during the quarter.
  • Exane Derivatives sold 1 iShares MSCI USA Value Factor ETF share in Q4 2020, an estimated $74.
  • Exane Derivatives first reported a position in iShares MSCI USA Value Factor ETF in Q3 2019 and held it in 5 quarters.
  • Exane Derivatives's iShares MSCI USA Value Factor ETF position peaked at $2.69M in Q4 2019.
  • 389 funds tracked by Wall St. Rank held iShares MSCI USA Value Factor ETF as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.